Phase II Pediatric Results A Boost For Replidyne’s Faropenem
Firm will not make a commitment to pursuing a Phase III trial for the antibiotic until a second-quarter meeting with FDA.
Firm will not make a commitment to pursuing a Phase III trial for the antibiotic until a second-quarter meeting with FDA.